[THE INVESTOR] As of July 25 02:40 P.M., CHA Biotech declined 1.21%, compared with yesterday, to 12,250 won(US$10.98). It had declined 1.21% through the past month. Standard deviation, the volatility index for stock price, was 1.3% on the same period of time over one month.

Compared with its close competitors within the same industry, KOSDAQ, CHA Biotech was not only satisfactory in investment return among its peer group, but its volatility was also relatively good. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -0.9%.
 
The return-on-risk is below the industrial mean, 0.6, and thus the industrial comparison performance was not so good.

By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.